{"adverse_reactions":["Sincerus Florida, LLC adverse reactions s"],"components":["Active, Inactive a"],"effective_time":"20200702","id":"a97a190f-1f99-1fb0-e053-2a95a90a6850","instructions_for_use":["Directions for use e"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-2208-2 011312 NIACINAMIDE 4% / TAZAROTENE 0.05% cream 30 gm d"],"set_id":"a97a190f-1f98-1fb0-e053-2a95a90a6850","spl_product_data_elements":["011312 NIACINAMIDE 4% / TAZAROTENE 0.05% 011312 NIACINAMIDE 4% / TAZAROTENE 0.05% TAZAROTENE TAZAROTENE NIACINAMIDE NIACINAMIDE"],"version":"1"}